| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) I-A3-ACC | RVI CHINA | 20,30% | 19,13% | -23,34% | · |
| ALLIANZ HIGH DIVIDEND ASIA PACIFIC EQUITY I (H-EUR) | RVI ASIA EX-JAPÓN | 20,29% | 35,91% | 21,32% | · |
| GAM MULTISTOCK EMERGING MARKETS EQUITY A CHF | RVI EMERGENTES | 20,29% | 34,49% | 11,43% | 45,93% |
| HSBC GIF HONG KONG EQUITY PD USD | RVI CHINA | 20,29% | 20,85% | -10,18% | 12,47% |
| SCHRODER ISF EMERGING MARKETS A1 ACC USD | RVI EMERGENTES | 20,29% | 37,28% | 20,72% | 76,91% |
| SCHRODER ISF SUSTAINABLE EMERGING MARKETS SYNERGY C ACC EUR | RVI EMERGENTES | 20,29% | 40,34% | · | · |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) F-ACC | RVI CHINA | 20,29% | 19,11% | -23,35% | 76,07% |
| AMUNDI FUNDS EMERGING MARKETS EQUITY GROWTH OPPORTUNITIES A EUR (C) | RVI EMERGENTES | 20,28% | 44,24% | 33,13% | · |
| LYXOR EURO STOXX 50 (DR) UCITS ETF ACC | RV EURO | 20,28% | 53,90% | 82,60% | 80,19% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP USD | BIOTECNOLOGÍA | 20,27% | 33,00% | 55,11% | 94,03% |
